All Articles

A Dell award for Unisys is more than a headline. It's a signpost for how enterprises must rebuild their digital foundations in the face of the AI revolution.

After teetering on the brink, AeroFarms' acquisition by a patient investor signals a crucial shift for the entire vertical farming sector, from VC hype to profitability.

The education giant swung from a massive loss to profit, not on textbooks, but on a strategic pivot to recurring digital revenue and a big bet on AI.

Binance's spot on the Fortune Crypto 100 is a mainstream win, but it masks a deeper story of regulatory battles and a high-stakes pivot to a financial super app.

Major academic centers no longer hold a monopoly on medical breakthroughs. A look at how community networks are democratizing cutting-edge cancer research.

Firat Eren rebuilt the cult-favorite barter app Bunz from the ashes. Now, he's given its users until September 1st to prove it's worth saving, or he'll delete it himself.

Bespin Global US's debut on the CRN SP500 is more than a press release. It's a signal of a market grappling with cloud costs, AI, and the need for new experts.

LiTime’s new Xtra Mini batteries are 40% smaller but promise EV-grade durability, signaling a major shift in how we power our mobile lives.

Sweeping data from EHA 2026 shows Syndax's Revuforj achieving remarkable success across leukemia settings, signaling a new standard of care and a major market coup.

Famed design firm Whipsaw is expanding beyond blueprints, hiring Roomba launch veteran Nancy Smith to build a new practice aimed at solving a key industry flaw.

A new currency vending machine in Saskatoon is more than a convenience; it's a signal of automation's next frontier in the battle for travel dollars.

With Thomas Winstanley at the helm, Edibles.com eyes dominance in the wellness-THC space. Can his CPG playbook conquer a booming but volatile market?

Yardi's long-running Changemakers sponsorship isn't just PR. It's a strategic investment to guide a market in flux and cement its role as an industry architect.

A $4M grant for a Parkinson's drug isn't just charity; it's a strategic bet on a new era of medicine, where philanthropy acts as the catalyst for the next big cure.

Elwood's integration with Kalshi isn't just a tech deal; it's a growth signal that prediction markets are getting the institutional rails they need to grow up.

A new global framework aims to bring accountability to income share agreements, a model hailed as an alternative to student debt but shadowed by controversy.

Cognizant's partnership with Oracle to deploy AI in recruiting highlights a critical trend: using automation to manage vast workforces and win the war for talent.

Relmada Therapeutics poaches a Sage neurosteroid expert for its sepranolone program. A look at the strategic rationale behind a move that signals big ambitions.

Stunning head-to-head trial data shows Takeda's zasocitinib is 2.5x more effective than its rival, signaling a major market disruption and validating a landmark deal.

WyreStorm unveils its Synergy Control Flow, betting on open-source logic and AI to slash AV integration time. Can this challenge the proprietary giants?